Filing Flows

Filing Flows › Companies › Clorox › Cash flow

Clorox cash flow, quarter by quarter

Latest: Q1 FY27 · from the cash-flow statements filed with the SEC

Free cash flow$105M in Q1 FY27

Operating cash flow$143M
Capital spending−$38.0M
Free cash flow+$105M
Cash / net income0.8×
Cash conversion cycle-33 days

Analysis

In Q1 FY27, Clorox generated $143M of operating cash flow and spent $38.0M on capital projects, leaving free cash flow of $105M. That is $48.0M more than in Q1 FY26 ($57.0M).

Operating cash flow was $143M against net income of $173M — 0.8× profit, less cash than reported earnings, worth checking against working capital. The largest differences: depreciation & amortization +$74.0M, payables −$68.0M, income taxes payable −$63.0M.

Its cash conversion cycle was -33 days (receivables 37 + inventory 63 − payables 133): suppliers fund its working capital.

Free cash flow

Clorox: free cash flow by quarterClorox: free cash flow by quarter$182MQ1 FY25$127MQ2 FY25$233MQ3 FY25$219MQ4 FY25$57.0MQ1 FY26$269MQ2 FY26−$165MQ3 FY26$105MQ1 FY27
Operating cash flow less capital spending.
Clorox: operating cash flow against capital spendingClorox: operating cash flow against capital spendingOperating cash flowCapital spending$221M$39.0MQ1 FY25$180M$53.0MQ2 FY25$286M$53.0MQ3 FY25$294M$75.0MQ4 FY25$93.0M$36.0MQ1 FY26$311M$42.0MQ2 FY26−$122M$43.0MQ3 FY26$143M$38.0MQ1 FY27
Latest (Q1 FY27): Operating cash flow $143M, Capital spending $38.0M.

Capital allocation, year by year

Clorox: where the cash came from (up) and went (down), by fiscal yearClorox: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksDividendsFY21: Operating cash flow $1.3BFY21: Net borrowing −$3.0MFY21: Shares issued $133MFY21: Capital spending −$331MFY21: Acquisitions −$85.0MFY21: Buybacks −$905MFY21: Dividends −$558M$1.4BFY21FY22: Operating cash flow $786MFY22: Net borrowing −$92.0MFY22: Shares issued $35.0MFY22: Capital spending −$251MFY22: Buybacks −$25.0MFY22: Dividends −$571M$821MFY22FY23: Operating cash flow $1.2BFY23: Net borrowing −$196MFY23: Shares issued $52.0MFY23: Capital spending −$228MFY23: Dividends −$583M$1.2BFY23FY24: Operating cash flow $695MFY24: Net borrowing −$56.0MFY24: Shares issued $23.0MFY24: Asset sales $17.0MFY24: Capital spending −$212MFY24: Dividends −$595M$735MFY24FY25: Operating cash flow $981MFY25: Net borrowing −$15.0MFY25: Shares issued $61.0MFY25: Asset sales $128MFY25: Capital spending −$220MFY25: Buybacks −$332MFY25: Dividends −$602M$1.2BFY25
Over these 5 years operating cash flow totalled $4.9B; the largest uses were dividends ($2.9B) and buybacks ($1.3B). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$167M
Debt$2.5B
Net debt$2.3B
Due within a year$4.0M

Clorox funds itself: free cash flow was — over the last twelve months, and $167M of cash and investments stands against $2.5B of debt ($4.0M due within a year, 41.8× covered by cash).

Clorox: debt maturities by year (FY25)Clorox: debt maturities by year (FY25)$900MYear 3$500MYear 4$500MYear 5$600MAfter year 5
Principal due in each year as disclosed in the annual report, against $167M of cash and investments now.

Where the cash came from and went

Clorox: sources (+) and uses (−) of cash, Q1 FY27Clorox: sources (+) and uses (−) of cash, Q1 FY27Dividends−$151MOperating cash flow$143MNet borrowing (+) / repaid (−)$89.0MCash drawn (+) / kept (−)−$40.0MCapital spending−$38.0MOther financing−$6.0MOther investing$3.0M

From profit to cash

Clorox: net income to operating cash flow, Q1 FY27Clorox: net income to operating cash flow, Q1 FY27Net income$173MDepreciation & amortization$74.0MStock-based pay$9.0MDeferred taxes$21.0MOther non-cash$4.0MReceivables$42.0MInventory−$4.0MPayables−$68.0MPrepaid and other assets−$44.0MIncome taxes payable−$63.0MOperating cash flow$143M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q1 FY273763133-33
Q3 FY263657163-70
Q2 FY263857188-93
Q1 FY264961207-98
Q3 FY253260169-77
Q2 FY253358142-52
Q1 FY253459142-50

Every quarter

QuarterOperating cash flowCapital spendingBuybacksDividendsNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q1 FY27$143M−$38.0M—−$151M$89.0M−$40.0M$105M
Q3 FY26−$122M−$43.0M—−$150M$1.3B−$958M−$165M
Q2 FY26$311M−$42.0M−$127M−$151M$89.0M−$60.0M$269M
Q1 FY26$93.0M−$36.0M−$129M−$151M$214M$1.0M$57.0M
Q4 FY25$294M−$75.0M−$75.0M−$150M−$50.0M$59.0M$219M
Q3 FY25$286M−$53.0M—−$150M−$134M$65.0M$233M
Q2 FY25$180M−$53.0M−$150M−$151M$184M−$12.0M$127M
Q1 FY25$221M−$39.0M−$107M−$151M—−$75.0M$182M

Clorox: income statement and cash flow

Clorox, Q1 FY27: revenue $1.9B (+33% year over year), operating margin 10.9%. The chart follows the revenue to costs, profit and cash.

Clorox: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.